Kyle Concannon

Supplementary Data1 from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco

Eleonora Gariazzo, Arielle Elkrief, Kyle Concannon, Daniele Ognissanti et autres

Data from Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco

Eleonora Gariazzo, Arielle Elkrief, Kyle Concannon, Daniele Ognissanti et autres

Abstract 6724: OncoTwin: A multimodal digital twin framework for predicting treatment response and guiding trial design in ALK-rearranged non-small-cell lung cancer.

Hui Xu, Yasir Y. Elamin, Lingzhi Hong, Kyle Concannon et autres

us (code pays fourni par la source)

Abstract 3166: TKI adaptive resistance in HER2-driven non-small cell lung cancer at minimal residual disease stage can be targeted using cell surface-directed therapies

Manale El Kharbili, Daniel Wilkinson, Lauren E. Giesy, Sharon R. Pine et autres

us (code pays fourni par la source)

The Impact of Targeting TRAF2 and NCK-Interacting Protein Kinase on Antitumor Effect and Tumor Immune Environment in c-MYC–High SCLC

Azusa Tanimoto, Kavya Ramkumar, C.Allison Stewart, Bingnan Zhang et autres

us (code pays fourni par la source)

PT2.11.01 Predictors of Response to PD-(L)1 Blockade in Patients With Oncogene-Driver Negative NSCLC Without History of Tobacco Use

Eleonora Gariazzo, A. Elkrief, Kyle Concannon, Damiano Ognissanti et autres

us, it, fr, my (code pays fourni par la source)

P1.11.56 Distinct Predictive Effects of PD-L1 Tps on Immunotherapy Outcomes and Immunophenotype in Squamous Versus Non-Squamous NSCLC

Valentina Santo, Arielle Elkrief, Kyle Concannon, Alessandro Di Federico et autres

Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant

Kyle Concannon, Robert L. Page, Rebecca Swayngim, Amrut V. Ambardekar et autres

us (code pays fourni par la source)

Thymo Limbo: Safety and Efficacy of Minimal-Dose Anti-Thymocyte Globulin Induction Therapy in Kidney Transplant Recipients

Kyle Concannon, S.E. Lawrence, V. Lewis, Fernando Jorge Delgado et autres

us (code pays fourni par la source)

Reconstructing Small Cell Lung Cancer Evolution using Deep Whole Genome Sequencing of Circulating Tumor DNA

Benjamin B. Morris, Zhihui Zhang, Andrew R. Lynch, Simon Heeke et autres

us (code pays fourni par la source)

Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with oncogene-driver negative NSCLC who have never smoked.

Eleonora Gariazzo, Arielle Elkrief, Kyle Concannon, Giulio Metro et autres

us, it, fr (code pays fourni par la source)

Differential predictive impact of PD-L1 expression on immunotherapy outcomes and immunophenotype in squamous versus non-squamous NSCLC.

Valentina Santo, Arielle Elkrief, Kyle Concannon, Alessandro Di Federico et autres

us (code pays fourni par la source)